ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 125 filers reported holding ARRAY BIOPHARMA INC in Q2 2013. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $48,109,000 | -53.3% | 1,038,390 | -75.4% | 1.10% | -62.0% |
| Q1 2019 | $103,101,000 | +15219.6% | 4,228,900 | +10437.2% | 2.91% | +16061.1% |
| Q2 2018 | $673,000 | +2.7% | 40,133 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $655,000 | +187.3% | 40,133 | +57.3% | 0.02% | +38.5% |
| Q1 2017 | $228,000 | -96.8% | 25,510 | -97.8% | 0.01% | -95.6% |
| Q3 2013 | $7,126,000 | +7997.7% | 1,145,740 | +5830.3% | 0.29% | +3155.6% |
| Q2 2013 | $88,000 | – | 19,320 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|